Endopar F

Endopar F is an FDA drug label for the active ingredient CIMICIFUGA RACEMOSA, FUCUS VESICULOSUS, OOPHORINUM (SUIS), HYPOPHYSIS SUIS, THYROIDINUM (SUIS), GRAPHITES, LACHESIS MUTUS, NATRUM MURIATICUM, PULSATILLA (PRATENSIS), SEPIA manufactured by Energique, Inc. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20230607.

Generic: CIMICIFUGA RACEMOSA, FUCUS VESICULOSUS, OOPHORINUM (SUIS), HYPOPHYSIS SUIS, THYROIDINUM (SUIS), GRAPHITES, LACHESIS MUTUS, NATRUM MURIATICUM, PULSATILLA (PRATENSIS), SEPIA

Manufacturer: Energique, Inc.

Product Type: HUMAN OTC DRUG

Route: ORAL

Dosage Form:

NDC: 44911-0308

Application:

Effective: 20230607

Active Ingredients: ACTIVE INGREDIENTS: (in each drop): 19.90% of Graphites 12X, Lachesis Mutus 12X, Natrum Muriaticum 12X, Pulsatilla (Pratensis) 12X, Sepia 12X; 0.10% of Cimicifuga Racemosa 3X, Fucus Vesiculosus 3X, , Hypophysis Suis 6X, Oophorinum (Suis) 6X, Thyroidinum (Suis) 6X.

Indications & Usage

INDICATIONS: May temporarily relieve menstrual pain and cramps, pain immediately prior to menses, and sore breasts associated with menstruation.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Dosage & Administration

DIRECTIONS: Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. If symptoms persist for more than 7 days, consult your health care professional. Consult a physician for use in children under 12 years of age.

Contraindications

Not available.

Warnings

WARNINGS: If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.

Adverse Reactions